Healthcare Defender: JJ Mosolf, President & Co-Founder | Academy Medtech Ventures, Inc.

It’s Cybersecurity Awareness Month! In healthcare, safeguarding cybersecurity is safeguarding patients. Whether it’s a hospital, health system, physician group, or a trusted digital health partner, when healthcare is attacked, patients are at risk. 

Join us all month as we feature some of healthcare’s fiercest defenders. They’re leaders from across the ecosystem fighting to protect data, systems, and care delivery. Join us to hear how they started, why they chose healthcare, and their advice for other leaders in their spaces. 

Today’s featured healthcare defender is JJ Mosolf, President and Co-Founder of Academy Medtech Ventures. JJ shares his journey from patient to digital health innovator, challenging the conventional healthcare model and working to bring innovation into the system. JJ also talks about the value of cybersecurity as foundational to earning patients’ trust and powering perpetual innovation.

Cybersecurity is patient safety. Do your part, be a healthcare defender. 

Related Blogs

Clear Perspective:  Managing Significant Changes in PCI DSS 4.0

Clear Perspective: Managing Significant Changes in PCI DSS 4.0

PCI DSS 4.0 introduces new guidelines that require organizations to define, evaluate, and document significant changes in their cardholder data environments. But what exactly counts as a "significant change," and how should businesses categorize and track them? Our expert guests provide practical insights and recommendations to help organizations stay compliant.
Clear Perspective: HITRUST Assessments- Key Insights for First-Timers

Clear Perspective: HITRUST Assessments- Key Insights for First-Timers

In this episode, we discuss some challenges first-time clients encounter when seeking HITRUST. Clearwater HITRUST Assessors will discuss the paths of a validated e1 and an i1 certification and clarify the various ways to indicate how an organization assesses and responds to the controls it has in scope for its assessment. They also discuss when and how to use the non-applicable vs. zero population. If you're curious about these nuances, listen to the discussion. 

Connect
With Us